Management of renal anaemia: comparison of practice in the Czech Republic and Northern England.
The EDTNA/ERCA European Practice Database (EPD) questionnaire was piloted in the Czech Republic (CZ), Northern Italy and Northern England (N-ENG) in early 2003. The questionnaire used in the CZ and N-ENG featured additional questions on the use of erythropoetin (EPO) and intravenous (IV) iron. There were significant differences in the policies for anaemia management in the CZ and N-ENG, reflecting the higher level of funding available to centres in the UK. There was also a wide variation in practice between the CZ centres, but not those in N-ENG, possibly due to the adoption of guidelines that are currently unrealistic. Some centres, particularly those in the CZ, could improve outcomes or reduce overall costs by adopting a more aggressive policy for the use of intravenous iron.
Lindley
Elizabeth
E
Department of Renal Medicine, Leeds Teaching Hospitals NHS Trust, UK.
Pancírová
Jitka
J
Kraciková
Jindra
J
Lopot
Frantisek
F
Green
Diane
D
Harrington
Maurice
M
De Vos
Jean-Yves
JY
Elseviers
Monique
M
D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D018153:Czech Republic; D004739:England; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D007501:Iron / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications*; D017410:Practice Guidelines as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use*
D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron